NewsFinale
  • Home
  • News
  • Local News
  • Business
  • Health
  • Finance
  • Celeb Lifestyle
  • Crime
  • Entertainment
  • Advertise Here
Gleammour AquaFresh
NewsFinale
  • Home
  • News
  • Local News
  • Business
  • Health
  • Finance
  • Celeb Lifestyle
  • Crime
  • Entertainment
  • Advertise Here
Home Local News State Medicaid Programs Seeking Solutions for Rising Cost of Weight-Loss Medications

State Medicaid Programs Seeking Solutions for Rising Cost of Weight-Loss Medications

The skyrocketing cost of weight-loss drugs has state Medicaid programs looking for a solution
Up next
Body found in Wisconsin River ID'd as Chicago man Luis Di Filippo; search for 2nd boater, Francesco Di Filippo, ongoing
Chicago Man Luis Di Filippo Identified as Body Found in Wisconsin River; Search Continues for Second Boater, Francesco Di Filippo
Published on 06 April 2025
Author
NewsFinale Journal
Share and Follow
FacebookXRedditPinterestWhatsApp


States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by surprise.

One solution some policymakers may try is restricting the number of people on Medicaid who can use the pricey diabetes drugs for weight-loss purposes.

Pennsylvania’s Medicaid coverage of the drugs is expected to cost $1.3 billion in 2025 — up from a fraction of that several years ago — and is contributing to projections of a multibillion-dollar budget deficit. The state is thinking about requiring Medicaid patients who want to use GLP-1s for weight loss to meet a certain number on the body-mass index or try diet and exercise programs or less expensive medications first.

“It is a medication that’s gotten a lot of hype and a lot of press, and has become very popular in its use and it is wildly expensive,” Dr. Val Arkoosh, Pennsylvania’s human services secretary, told a state House hearing in March.

At least 14 states already cover the cost of GLP-1 medications for obesity treatment for patients on Medicaid, the federal health care program for people with low incomes. Democrats and Republicans in at least a half-dozen other states floated bills this year to require the same coverage, according to an Associated Press analysis using the bill-tracking software Plural.

Some bills have stalled while others remain alive, including a proposal in Arkansas requiring GLP-1s to be covered under Medicaid when prescribed specifically for weight loss. Iowa lawmakers are thinking about ordering a cost-benefit analysis before making the commitment. Already, West Virginia and North Carolina ended programs in 2024 that provided coverage for state employees, citing cost concerns.

“It is very expensive,” said Jeffrey Beckham, the state budget director in Connecticut, where Medicaid coverage of the drugs for weight loss may be scrapped entirely. “Other states are coming to that conclusion, as well as some private carriers.”

Overall Medicaid spending on GLP-1 drugs — before partial rebates from drug manufacturers — jumped from $577.3 million in 2019 to $3.9 billion in 2023, according to a November report from KFF, a nonprofit that researches health care issues. The number of prescriptions for the drugs increased by more than 400% during that same time period. The average annual cost per patient for a GLP-1 drug is $12,000, according to a Peterson-KFF tracker.

About half of Americans “strongly” or “somewhat” favor having Medicare and Medicaid cover weight-loss drugs for people who have obesity, a recent AP-NORC poll showed, with about 2 in 10 opposed the idea and about one-quarter with a neutral view.

But Medicare does not cover GLP-1s, and the Trump administration said Friday that wouldn’t put into place a proposed rule by presidential predecessor Joe Biden to cover the medications under Medicare’s Part D prescription drug coverage. Biden’s proposal was expensive: It would have included coverage for all state- and federally funded Medicaid programs, costing taxpayers as much as $35 billion over next decade.

States that do provide coverage have tried to manage costs by putting prescribing limits on the GLP-1s. There’s also some evidence that if Medicaid patients lose weight with the drugs, they’ll be healthier and less expensive to cover, said Tracy Zvenyach of Obesity Action, an advocacy group that urges states to provide coverage.

Zvenyach also stressed how it’s unclear whether patients will need to regularly take these drugs for the rest of their lives — a key cost concern raised by public officials. “Someone may have to be on treatment for over the course of their lifetime,” she said. “But we don’t know exactly what that regimen would look like.”

About 40% of adults in the U.S. have obesity, according to the U.S. Centers for Disease Control and Prevention. Obesity can cause hypertension, Type 2 diabetes and high cholesterol, which lead to greater risks of things like stroke and heart attacks.

Dr. Adam Raphael Rom, a physician at Greater Philadelphia Health Action, a network of health centers in the city, said most of his patients who take GLP-1s are covered by Medicaid and some are non-diabetics who use it for weight loss.

“I had one patient tell me that it’s like, changed her relationship to food,” Rom said. “I’ve had patients lose like 20, 40, 60 pounds.”

But obesity experts have told The Associated Press that as many as 1 in 5 people may not lose the amount of weight that others have seen come off. And in a recent survey of state Medicaid directors conducted by KFF, a health policy research organization, they said cost and potential side effects are among their concerns.

The debate over coverage coincides with rising Medicaid budgets and the prospect of losing federal funding — with congressional Republicans considering siphoning as much as $880 billion from Medicaid over the next decade.

Connecticut is facing a $290 million Medicaid account deficit, and Democratic Gov. Ned Lamont proposed doing away with a 2023 requirement that Medicaid cover GLP-1s for severe obesity, though the state has never fully abided by the law due to the cost.

Starting June 14, though, state Medicaid patients will be required to have a Type 2 diabetes diagnosis to get the drugs covered. Lamont also is pushing for the state to cover two less expensive oral medications approved by the FDA for weight loss, as well as nutrition counseling.

Sarah Makowicki, 42, tried the other medications and said she suffered serious side effects. The graduate student and statehouse intern is working on a bill that would restore the full GLP-1 coverage for her and others.

Sara Lamontagne, a transgender woman with a disability who is on Medicaid, said she regained weight when her coverage for GLP-1 medication was cut off in the past. She said she went from 260 pounds to over 300, heavier than she had ever been.

“So, it’s a horrible game to be played, to be going back and and forth,” said Lamontagne, whose attempts to appeal the state’s recent denial of her Ozempic prescription refill have been unsuccessful.

Makowicki said GLP-1 drugs combined with weight-loss surgery helped her change her life: She’s had knee-replacement surgery and lost over 200 pounds.

“I am a different person from what I was five years ago,” Makowicki said. “Not only in my physical space, but also mentally.”

___

Haigh reported from Hartford, Connecticut. Levy reported from Harrisburg, Pennsylvania.

Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

Share and Follow
FacebookXRedditPinterestWhatsApp
You May Also Like
At least 13 dead in Texas floods and more than 20 children missing from a girls summer camp
  • Local News

At least 13 dead in Texas floods and more than 20 children missing from a girls summer camp

KERRVILLE, Texas (AP) — Months worth of heavy rain fell in a…
  • NewsFinale Journal
  • July 4, 2025

24 confirmed dead in Texas flooding; two dozen girls missing from camp

(NewsNation) — The sheriff of Kerr County, Texas, said Friday night that…
  • NewsFinale Journal
  • July 5, 2025
VIDEO: 2 injured after fireworks incident on Boone Lake
  • Local News

Two individuals injured in accident involving fireworks at Boone Lake

SULLIVAN COUNTY, Tenn. (WJHL) — Two people were reportedly injured after a…
  • NewsFinale Journal
  • July 5, 2025
Nick Hankins Jr. discusses Illinois football commitment
  • Local News

Illinois football commitment explained by Nick Hankins Jr.

BELLEVILLE, Ill. (WCIA) — Recruiting the state of Illinois continues to be…
  • NewsFinale Journal
  • July 5, 2025
World's largest Legoland opens to tourists in Shanghai
  • Local News

The biggest Legoland in the world now welcomes visitors in Shanghai

A view of Legoland Shanghai a day before it opens to the…
  • NewsFinale Journal
  • July 5, 2025
Brazilian hiker buried after fatal fall from Indonesian volcano
  • Local News

Death of Brazilian hiker in Indonesian volcano fall leads to burial

Manoel Marins, center, and Estela Marins, left, meet with friends during the…
  • NewsFinale Journal
  • July 4, 2025
Storm Team 3: Tracking the Tropics this weekend
  • Local News

Monitoring Tropical Weather this weekend with Storm Team 3

This weekend’s main weather driver will be Tropical Storm Chantal, currently circulating…
  • NewsFinale Journal
  • July 5, 2025
Trump branded, browbeat and prevailed. But his big bill may come at a political cost
  • Local News

Trump was successful through his forceful actions, but there could be consequences for his major decision.

WASHINGTON – Barack Obama had the Affordable Care Act. Joe Biden had…
  • NewsFinale Journal
  • July 5, 2025
A fragile ceasefire in the Israel-Iran war tests the harmony of Los Angeles' huge Iranian community
  • US

A delicate truce in the conflict between Israel and Iran challenges the unity of the large Iranian population in Los Angeles.

LOS ANGELES (AP) — “Tehrangeles” in West Los Angeles is home to…
  • NewsFinale Journal
  • July 5, 2025
Taylor Swift Fans Defended Her Amid Claims She Scammed People With Her 'Taylor's Version' Releases
  • Entertainment

Supporters of Taylor Swift stood up for her against allegations that she deceived individuals through her ‘Taylor’s Version’ music releases

Taylor Swift recently told fans that she repurchased the rights to her…
  • NewsFinale Journal
  • July 5, 2025
Girl clinging to a tree in floodwaters.
  • News

Woman, 22, swept 20 MILES by Texas floods & left clinging to tree in rescue… but 25 children still missing from camp

A YOUNG woman was miraculously rescued after being swept 20 miles downriver…
  • NewsFinale Journal
  • July 5, 2025
‘Seinfeld’ writer details the cocaine-fueled chaos of making ‘80s TV shows
  • Celeb Lifestyle

“Insight into the Turbulent Production of 1980s TV Shows from a ‘Seinfeld’ Writer”

Veteran sitcom writer Larry Charles says cocaine was rampant in Hollywood during…
  • NewsFinale Journal
  • July 5, 2025
NewsFinale Journal
  • Home
  • Terms and Conditions
  • Sitemap
  • DMCA
  • Advertise Here
  • Donate